MCEDC Interview: Jeff Galvin, CEO & Founder of American Gene Technologies
In the latest of the ‘Built for Bio‘ interview series, MCEDC CEO, David Petr, discovers how Jeff is using the availability of raw talent and novel technology unique to Montgomery County, MD to develop potential cures for HIV and cancers using cell and gene therapy.
Jeff’s passion for his company, his people and the region is a hallmark of his leadership. His enthusiasm for the possibilities that cell and gene therapy technologies are enabling for patients is what fuels that passion.
“This is more important than any revolution in technology that has come before.”Jeff Galvin, CEO, American Gene Technologies
Latest posts by Chris Frew (see all)
- Why the BioHealth Capital Region Needs to Do More To Attract Top Talent - February 18, 2020
- VerImmune Inc Appoints Oncology Veteran as Interim Chief Business Officer - February 18, 2020
- Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million from Germantown, Maryland’s Orgenesis Inc. - February 3, 2020